2min chapter

The David Rubenstein Show cover image

Anne Wojcicki

The David Rubenstein Show

CHAPTER

23andMe Therapeutics

23andMe is largely seen as a consumer company. Can you transform your company into being a tech or biotech company by working on disease solutions? That's actually one of the beauties. We have over 50 programs that are in development. And we have two actually in clinical trials. So we're 100 like absolutely thinking about how people will benefit from the human genome.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode